Search

Search Constraints

You searched for: Author/Creator Abboud, Miguel R.

Search Results

1. 13‐valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6‐17 years of age with sickle cell disease previously vaccinated with 23‐valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study. Issue 8 (23rd March 2015)

2. 13‐valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6‐17 years of age with sickle cell disease previously vaccinated with 23‐valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study. Issue 8 (23rd March 2015)

3. A dose‐escalation phase IIa study of 2, 2‐dimethylbutyrate (HQK‐1001), an oral fetal globin inducer, in sickle cell disease. Issue 11 (3rd October 2013)

4. A double‐blind, placebo‐controlled phase II study of the efficacy and safety of 2, 2‐dimethylbutyrate (HQK‐1001), an oral fetal globin inducer, in sickle cell disease. Issue 7 (15th April 2014)

6. Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and management. Issue 12 (29th June 2017)

9. Genetic polymorphisms in candidate genes are not associated with increased vincristine-related peripheral neuropathy in Arab children treated for acute childhood leukemia: a single institution study. Issue 8 (August 2018)

10. Heritable cancer predisposition testing in pediatric cancer patients excluding retinoblastoma in a middle‐income country. Issue 11 (12th September 2022)